Biocept announces a provider agreement with Alliance Global FZ to market and distribute Biocept’s Target Selector liquid biopsy tests in the United Arab Emirates and select countries in the Middle East, North & Sub-Saharan Africa, and Southeast Asia region. All diagnostic testing services under this agreement will be performed in Biocept’s San Diego-based CLIA-certified laboratory with Alliance Global having responsibility for sales, marketing, distribution, and reimbursement of the Company’s liquid biopsy platform. Additional terms of the agreement were not disclosed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.